Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m unpaid ihub poster so I couldn’t access your suppressed image. Was wondering what I’m missing?
Do we have any eyes and/or ears at this UK conference?
Any chance of live or delayed netcast?
People, people who need people
Are the luckiest people, in the world!
A real oldie but goodie!
PM, you’re a good ‘em and would offer the park bench under your back to an under their luck soul with no place to sleep.
God bless and GLTA
Is there something very important in the image you shared?
I’m not able to access it as a no paid member of this board.
TIA
BB, sorry to be a dunce, but are those times for Thursday morning ET USA or Friday morning?
That’s right
Who’s on first
That’s right
Who is the player on first
That’s right
Idunno
Third base!
Btw from a story on NW that I recently read, looks like NW stepped out of fund management of his fund family and another entity (Link, I think) did liquidations that we’re not popular nor well explained.
Is this another potential venue for positive developments or does novacure sponsorship bode a non mention or negative mention?
View on a browser
ABTA Patient & Family Meetings
Three Days Away! Advances in Brain Tumor Research and Clinical Trials
Saturday, June 25
10 AM CT
Join this free, half-day virtual meeting to learn about new therapies, accessing clinical trials, and challenges in developing a cure(s) for brain tumors.
Meeting topics include:
Understanding the different stages of research and clinical trials
How new therapies are developed and tested
Barriers affecting development of cures
LEARN MORE & REGISTER
Meeting Chair Dr. Michael A. Vogelbaum, MD, PhD, Moffitt Cancer Center
Meeting Chair:
Dr. Michael A. Vogelbaum, MD, PhD
Chief of Neurosurgery
Moffitt Cancer Center
Our meeting sponsor:
Novocure
Looking for a treatment center? We can help!
Doctor and elderly patient
Whether you're newly diagnosed or seeking a second opinion, choosing the right brain tumor treatment center is one of several important decisions you'll make.
A free online search tool on the ABTA website offers detailed information on treatment centers in your community, including the technology and specialized procedures available, the number of patients treated annually, and more.
Find A Brain Tumor Treatment Center
Facebook
Twitter
Instagram
YouTube
LinkedIn
Copyright © 2022 American Brain Tumor Association. All rights reserved.
You are receiving this email because of your interest in the American Brain Tumor Association.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
Unsubscribe
FUD alert!!!!!
Depends on the timing. Immediate need can be manually produced. Semi manual is probably technically available and could be used if equivalence testing has been done. Automated may be available in fairly short order, and again, equivalence testing must be completed before use.
Imo of course.
Maybe NW still has a personal stake in nwbo shares?
Maybe just dreaming, however wouldn’t it be something if Drs Stupp & Ashkan get followed up by some positive UK RA or NICE news!
No worries!
I’m stronger and longer nwbo than ever!
If some unexpected reason should arise to change my committed beliefs I would go into the detailed reason(s) for such a drastic change of view.
I do not expect such an event to occur and I’m biding the time until the series of very positive news/catalysts break publicly!
Can’t happen too soon for me as I’m trying to get to an acceptable design vs affordability for the retirement house to be built in Georgia, and materials and labor costs have risen quite a bit. A higher nwbo stock price would help tremendously.
Bio,
The message I was responding to from FeMike asked me when I would stop believing? To which I answered when dcvax isn’t approved in the UK, which I take UK approval as extremely likely and therefore expect to keep believing.
The original message was removed, so my positive and supportive message came across opposite of the intent.
You can see the rest is also supportive.
When dcvax doesn’t get approved at least in the Uk.
Also, I don’t remember 2017 statements about TLD, especially considering the trial wasn’t data locked.
I do remember being informed that the scientific advisory board recommended extending the trial enough to capture actual long tail statistics, and glad they took the advice.
My share count has only risen over the years because while taking a longer time than expected, nwbo has delivered approvable TL Results!
They also worked manufacturing along with a strategic FlaskWorks acquisition with the founders on board and the IP.
This might be late but first success in GBM treatment in decades and 400-500 other failed treatments.
Did a little birdie paint this future ?
How about Elvis comes back from hiding and delivers the journal paper orally in Las Vegas?
My vision is about as valid as the one you painted.
We both don’t know because we are not insiders however the company has told us the peer reviewed paper is vitally important and coming.
I believe the company !
As I’ve opined previously, the focus is on the goal of DCVax approval, and although management may care about common shareholders, we are secondary at best and somewhat fungible (proper usage?) if deemed necessary to advance the primary goal.
I’ve long felt that way and accepted the prospect of some collateral damage.
In any event I think we are past the collateral damage phase unless we get a big dilutive financing, which I think has been avoided recently.
LP wouldn’t want to disappoint the monks at the ASM. They’re capable of a deadly silent treatment I hear
I had a dream we close nicely green today and the FUDsters all turned into ducks and quacked away, all in a row
FUD alert!!!!!!!!!!!!!!
Scotty, multiple personalities?
All the FUDsters out in force this morning!
I guess long weekend cut a payday and making it up in volume of FUD.
Here’s to hoping we have a good week, and glta and to all a good night!
At the risk of being the Good Samaritan who becomes injured by trying to break up a rumble, why get all worked up over secondary or tertiary issues now when we are closing in on the primary objectives?
If we make the primary objectives then we’ll be in a strong position to address the follow on matters. If we somehow don’t achieve the primaries, then it might not matter or maybe it’s a firesale.
Peace and love, peace and love!
If nothing else, recruiting trial participants should be much quicker after a successful GBM phase 3!
I tend to agree that it was more of a spontaneous reply
You also know that the clause you reference is invoked after the first funding raise after TLD is released, not just TLD.
And I’m sure you’re aware of the other theory that the company officially releasing TLD might violate a journal embargo.
Oh, but I forgot, you don’t believe there is a pending journal paper.
BTW from seeing the process of journal submission at arms length a couple of times, the process can easily take 6-9 months for a one or two authored paper to go from submittal to acceptance and peer editing to targeting the issue to public availability, when Covid wasn’t to happen for years.
Now factor in a large number of authors around the world, and peer review cycles, during the throes of Covid, and twice or more the interval is not so questionable.
One can only hope this time will be different
Best wishes to you!
Top line results have been made available May 10 and reinforced at ASCO, where nwbo expanded on what manual and closed loop vaccine manufacturing entails, indicating in depth knowledge of what is required, including the assays, etc.
Also, no less than three world leading GBM treating neurosurgeons expressing unbridled support of the phase 3 trial results and clinical observations.
The elapsed time has been long and frustrating but the risk reward has never been better and should improve with each remain8ng catalyst.
You’re apparently taking a glass half empty view rather than a half full outlook, despite all recent indications that there has been more work and progress accomplished, with more coming, behind the scenes!
Sawston and UK look swimmingly good old chap! Odds of UK approval looking very good.
GBM community waiting with anticipation for the peer reviewed paper which will be published with 99.99% probability.
Once validated there will be an acceptance and adoption of the treatment that is currently the only advance and offers hope!
What does neil Woodford do now?
Woodford plans new company launch
In February 2021, during an interview with The Daily Telegraph, Neil Woodford revealed that he wanted to launch a brand-new investment company called Woodford Capital Management (WCM) Partners. The firm, he said, would operate out of Jersey and Buckinghamshire.Aug 12, 2021
https://www.moneymarketing.co.uk › ...
As like the rest of us, Woodford probably believed in the DCVax platform and chose to hang on to the shares waiting for the investment to make good.
However he ran out of time with a streak of investments that tanked his managed funds, leading to their demise.
I think Woodford may be resurrecting his investment activities in some new form, but that’s only rumor or third hand rumblings and not reliable information.
There was a definite sense of an unfriendly takeover attempt, or wrestling of control, and it seemed to me that Woody was involved, not only by his large investment in nwbo shares at the market, but with his bringing other players to nwbo and insisting that LP let them into the inner sanctum.
The questionable connections and attempts to get at key manufacturing information came out, and LP held her ground and then some, as painful as it would be to endure.
I suspected Woody saw the ultimate value and wanted to position himself and others outside nwbo to gain control.
Just imho
Let’s hope we don’t get a new meaning in Funk & Wagnells for the term clubbing.
Contemporary usage: my friends and I were out clubbing last night (meaning out to night clubs to enjoy music and spirits)
Potential new usage: My wife went out clubbing last night (meaning taking a 9 iron along on a search through parks aiming to transfer maximum momentum from the club head to the targeted head after yelling out “4 nwbo!)
For everyone’s sake, very, very soon!
Good news, but keep the protective gear close by just in case.
I believe the tall thin monk stated nwbo’s fortune as, “Yo dog, nwbo’s the sh_t !”
I think Woodford invested over $100M, like $180M in nwbo, but it’s been a long time and no longer have the memory of an elephant, just the body shape
Oribis or Orbis?
Thank you, yes, project Orbis!
Seems like the most efficient process for getting multiple RA approvals, although I don’t know if other constraints apply that would negate the hoped for streamlining of Project Orbis?
Gotcha PM !
Better yet, nwbo traders are at home in their daily drives, like Cramer said he lived out of his car in his early days.
Like Cramer did, nwbo traders will soon be able to move out of the vehicles and into a finely appointed Winnebago!
Yes, thanks! The routine might have been done by both shows, especially given the vaudeville roots.